Skip to main content
Log in

Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

In previous studies, we observed a positive association between Trichomonas vaginalis serostatus and risk of prostate cancer, particularly aggressive cancer, which we hypothesized might be due to T. vaginalis-mediated intraprostatic inflammation and cell damage. To explore this hypothesis further, we investigated effect modification by Toll-like receptor 4 (TLR4) variation on this association. We hypothesized that TLR4 variation might serve a marker of the anti-trichomonad immune response because T. vaginalis has been shown to elicit inflammation through this receptor.

Methods

We previously genotyped the non-synonymous TLR4 single nucleotide polymorphism (SNP), rs4986790, and determined T. vaginalis serostatus for 690 incident prostate cancer cases and 692 controls in a nested case–control study within the Health Professionals Follow-up Study.

Results

A non-significant suggestion of effect modification was observed by rs4986790 carrier status on the association between T. vaginalis serostatus and prostate cancer risk (p interaction = 0.07). While no association was observed among men homozygous wildtype for this SNP (odds ratio (OR) = 1.23, 95 % confidence interval (CI): 0.86–1.77), a positive association was observed among variant carriers (OR = 4.16, 95 % CI: 1.32–13.1).

Conclusions

Although not statistically significant, TLR4 variation appeared to influence the association between T. vaginalis serostatus and prostate cancer risk consistent with the hypothesis that inflammation plays a role in this association. Larger studies will be necessary to explore this possible effect modification further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holmes KK, Sparling PF, Stamm WE et al (eds) (2008) Sexually transmitted diseases, 4th edn. McGraw-Hill Medical, New York

    Google Scholar 

  2. Wynder EL, Mabuchi K, Whitmore WF Jr (1971) Epidemiology of cancer of the prostate. Cancer 28(2):344–360

    Article  PubMed  CAS  Google Scholar 

  3. Gardner WA Jr, Culberson DE, Bennett BD (1986) Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110(5):430–432

    PubMed  Google Scholar 

  4. Smith CJ, Gardner WA Jr (1987) Inflammation-proliferation: possible relationships in the prostate. In: Coffey DS, Bruchovsky N, Gardner WA, Resnick MI, Karr JP (eds) Current concepts and approaches to the study of prostate cancer. Alan R. Liss, Inc., New York, pp 317–25

  5. Sutcliffe S, Giovannucci E, Alderete JF et al (2006) Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(5):939–945

    Article  PubMed  CAS  Google Scholar 

  6. Stark JR, Judson G, Alderete JF et al (2009) Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians’ Health Study. J Natl Cancer Inst 101(20):1406–1411

    Article  PubMed  Google Scholar 

  7. Sutcliffe S, Alderete JF, Till C et al (2009) Trichomonosis and subsequent risk of prostate cancer in the prostate cancer prevention trial. Int J Cancer 124(9):2082–2087

    Article  PubMed  CAS  Google Scholar 

  8. Zariffard MR, Harwani S, Novak RM et al (2004) Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin Immunol 111(1):103–107

    Article  PubMed  CAS  Google Scholar 

  9. Chang JH, Kim SK, Choi IH et al (2006) Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation. Int J Biochem Cell Biol 38(4):638–647

    Article  PubMed  CAS  Google Scholar 

  10. Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5(3):156–164

    PubMed  Google Scholar 

  11. den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ (2010) Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209(2):314–320

    Article  Google Scholar 

  12. Chen YC, Giovannucci E, Lazarus R et al (2005) Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 65(24):11771–11778

    Article  PubMed  CAS  Google Scholar 

  13. Wang A, Wang CC, Alderete JF (1987) Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus. J Exp Med 166(1):142–150

    Article  PubMed  CAS  Google Scholar 

  14. Khoshnan A, Alderete JF (1995) Characterization of double-stranded RNA satellites associated with the Trichomonas vaginalis virus. J Virol 69(11):6892–6897

    PubMed  CAS  Google Scholar 

  15. Lehker MW, Alderete JF (1992) Iron regulates growth of Trichomonas vaginalis and the expression of immunogenic trichomonad proteins. Mol Microbiol 6(1):123–132

    Article  PubMed  CAS  Google Scholar 

  16. Alderete JF (1999) Iron modulates phenotypic variation and phosphorylation of P270 in double-stranded RNA virus-infected Trichomonas vaginalis. Infect Immun 67(8):4298–4302

    PubMed  CAS  Google Scholar 

  17. Lehker MW, Arroyo R, Alderete JF (1991) The regulation by iron of the synthesis of adhesins and cytoadherence levels in the protozoan Trichomonas vaginalis. J Exp Med 174(2):311–318

    Article  PubMed  CAS  Google Scholar 

  18. Alderete JF, Provenzano D, Lehker MW (1995) Iron mediates Trichomonas vaginalis resistance to complement lysis. Microb Pathog 19(2):93–103

    Article  PubMed  CAS  Google Scholar 

  19. Garcia AF, Benchimol M, Alderete JF (2005) Trichomonas vaginalis polyamine metabolism is linked to host cell adherence and cytotoxicity. Infect Immun 73(5):2602–2610

    Article  PubMed  CAS  Google Scholar 

  20. Provenzano D, Alderete JF (1995) Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect Immun 63(9):3388–3395

    PubMed  CAS  Google Scholar 

  21. Lama A, Kucknoor A, Mundodi V, Alderete JF (2009) Glyceraldehyde-3-phosphate dehydrogenase is a surface-associated, fibronectin-binding protein of Trichomonas vaginalis. Infect Immun 77(7):2703–2711

    Article  PubMed  CAS  Google Scholar 

  22. Alderete JF, Newton E, Dennis C, Neale KA (1991) The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases. Genitourin Med 67(6):469–474

    PubMed  CAS  Google Scholar 

  23. Kucknoor AS, Mundodi V, Alderete JF (2007) The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol 9(11):2586–2597

    Article  PubMed  CAS  Google Scholar 

  24. Kucknoor AS, Mundodi V, Alderete JF (2005) Adherence to human vaginal epithelial cells signals for increased expression of Trichomonas vaginalis genes. Infect Immun 73(10):6472–6478

    Article  PubMed  CAS  Google Scholar 

  25. Zheng SL, Augustsson-Balter K, Chang B et al (2004) Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden study. Cancer Res 64(8):2918–2922

    Article  PubMed  CAS  Google Scholar 

  26. Cheng I, Plummer SJ, Casey G, Witte JS (2007) Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev 16(2):352–355

    Article  PubMed  CAS  Google Scholar 

  27. Wang MH, Helzlsouer KJ, Smith MW et al (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate 69(8):874–885

    Article  PubMed  CAS  Google Scholar 

  28. Stark JR, Wiklund F, Gronberg H et al (2009) Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev 18(6):1859–1863

    Article  PubMed  CAS  Google Scholar 

  29. Lindstrom S, Hunter DJ, Gronberg H et al (2010) Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol Biomarkers Prev 19(3):873–876

    Article  PubMed  CAS  Google Scholar 

  30. Shui IM, Stark JR, Penney KL et al (2012) Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate 72(2):209–216

    Google Scholar 

Download references

Acknowledgments

Funding for this study was provided by grants from the US National Cancer Institute (U01 CA98233 and CA55075). Siobhan Sutcliffe was funded by the Barnes-Jewish Hospital Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yen Ching Chen.

Additional information

Yen-Ching Chen and Yi-Ling Huang contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 311 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Y.C., Huang, Y.L., Platz, E.A. et al. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer. Cancer Causes Control 24, 175–180 (2013). https://doi.org/10.1007/s10552-012-0103-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-012-0103-y

Keywords

Navigation